Please assess the completion status of the following clinical trial:

Trial Title: HPV Vaccination Study in Postpartum Women

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participants biologically born as females between the ages of 15 through 45 who have delivered a live born baby within the past 72 hours.~Exclusion Criteria:~* Pregnancy~* Severe allergic reaction to vaccine components~* Prior receipt of an HPV vaccine dose~* Fetal demise or stillbirth~* Allergy to latex or yeast~* Moderate or severe acute illness (deemed by the investigator to exclude)~* Immunosuppression (e.g., HIV, solid organ transplant).

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Gardasil9 (Type: EXPERIMENTAL): Two doses of the 9-valent HPV vaccine to be administered to participants at 0 and 6 months. Additional HPV vaccine dose will be offered after final blood draw at 12 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).